Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA Denies Citizen Petition To Amend OTC Topical Drugs Monograph

This article was originally published in The Tan Sheet

Executive Summary

FDA cites insufficient evidence in rejecting a citizen petition filed by a New Jersey podiatrist to amend the proposed monograph for topical OTC First Aid Antibiotic Drug Products

You may also be interested in...

Topical antibiotics

Inclusion of bacitracin/polymyxin/vitamin E/mixed oils ointment in OTC monograph requested by New Jersey podiatrist in citizen petition to FDA. Petition asks agency to lower required dosages of bacitracin, polymyxin and allow distribution of combo containing polymyxin B-sulfate (892 units/g of finished product), bacitracin zinc (44.05 units/g), vitamin E (141 IU/g) and blend of paraffin, fragrance, mineral oil, cod liver oil, lanolin and petrolatum...

People In Brief

Perrigo promotes in pricing, planning

In Brief

Combe sells most of its OTC brands





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts